Designing and Implementing a Safety Net Surveillance Program for High Risk CKD

Condition(s) studied

Investigational drug(s) / intervention(s)

Letter to participants: Individuals randomized to the intervention group will received a direct mailing consisting of: 1. A letter explaining the purpose of the study and the benefits of screening for CKD, with contact information for the study team at Seven Oaks General Hospital / Chronic Disease Innovation Centre, who they may contact to receive further information and to book a follow-up appointment with a Clinical Assistant/Nephrologist 2. A brief fact sheet on CKD A follow-up reminder letter will be sent at 3 months in individuals that do not respond to the initial invitation.

Study summary

The objective of this initiative is to develop and evaluate a risk-based, provincial public health screening program for chronic kidney disease (CKD) that provides proactive care for adults at high-risk of kidney failure who have not previously been referred to a nephrologist, through risk stratification, triage, education, and follow-up.

Overall, we aim to demonstrate that an integrated risk-based provincial public health screening program for CKD is feasible, and improves identification of high-risk individuals, subsequently creating a model of care that can be adopted by other jurisdictions.

Eligibility

Primary outcome measure(s)

• Composite of kidney failure and all-cause mortality — within 12 months of letter mailout
  Kidney failure defined as dialysis, kidney transplantation. Collected using provincial administrative databases accessed through the MCHP

Trial sites (1)

More University of Manitoba trials in Canada

Other trials for the same condition